Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Precision Drilling
PDS
5
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
CMRX Chimerix
- 8.520
- -0.010-0.12%
Trading Apr 11 11:29 ET
799.21MMarket Cap-8.61P/E (TTM)
8.530High8.520Low518.01KVolume8.530Open8.530Pre Close4.42MTurnover0.66%Turnover RatioLossP/E (Static)93.80MShares8.55052wk High6.57P/B670.85MFloat Cap0.75052wk Low--Dividend TTM78.74MShs Float58.040Historical High--Div YieldTTM0.12%Amplitude0.750Historical Low8.525Avg Price1Lot Size
About Chimerix Company
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Company Profile
SymbolCMRX
Company NameChimerix
Listing DateApr 11, 2013
Issue Price14.00
Founded2000
CEOMr. Michael T. Andriole
MarketNASDAQ
Employees81
Fiscal Year Ends12-31
Address2505 Meridian Parkway,Suite 100
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-806-1074
Websitehttp://www.chimerix.com
Company Executives
- Name
- Position
- Salary
- Michael T. Andriole
- Director, Chief Executive Officer and President
- 1.31M
- Thomas J. Riga
- Chief Operating Officer and Chief Commercial Officer
- --
- Dr. Allen S. Melemed
- Chief Medical Officer
- 931.79K
- Michelle LaSpaluto
- Chief Financial Officer
- --
- David Jakeman
- Vice President, Finance and Accounting and Principal Accounting Officer
- --
- Dr. Michael A. Alrutz,PhD
- Senior Vice President, General Counsel and Corporate Secretary
- 793.85K
- Michael A. Sherman, M.B.A.
- Chairman of the Board
- 1.52M
- Marc D. Kozin
- Director
- --
- Victoria Vakiener
- Independent Director
- 107.02K
- Martha J. Dei
- Lead Independent Director
- 144.52K
- Lisa Lynn Decker, PhD
- Independent Director
- 67.78K
- Fred A. Middleton
- Independent Director
- 119.52K
- Dr. Robert J. Meyer, M.D.
- Independent Director
- 117.02K
- Dr. Pratik S. Multani, M.D.
- Independent Director
- 104.52K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
